Senna Plus description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Senna Plus

Geri-Care Pharmaceutical Corp
Geri-Care Pharmaceutical Corp


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

Active ingredient (in each tablet)

Docusate Sodium 50 mg
Sennosides 8.6 mg

Purpose

Stool softener

Laxative

Senna Plus Uses

  • relieves occasional constipation (irregularity)
  • generally produces bowel movement in 6 to 12 hours

Warnings

Do not use for more than 1 week unless directed by a doctor

Ask a doctor before use if you -have abdominal  pain, nausea or vomiting -are taking mineral oil -have noticed a sudden change in bowel habits that  lasts over 2 weeks

Stop use and ask a doctor if -you have no bowel movement within 12 hours -you have rectal bleeding. these could signs of a serious condition.

if pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

• do not exceed 8 tablets in 24 hours

Age
Starting Dose
Maximum Dose
adults and children 12 years of age and older
2 tablets once a day preferably at bedtime; increase as needed, or as directed by a doctor
4 tablets in the morning and 4 tablets at bedtime
children under 12 years
ask a doctor

Senna Plus Other information

each tablet contains: calcium 7 mg

• store at room temperature

Inactive ingredients

cellulose, croscarmellose sodium, dicalcium phosphate, FD and C yellow no. 5 (tartrazine), FD and C yellow no. 6, hypromellose, magnesium silicate, magnesium stearate, mineral oil, PEG, sodium benzoate, sodium lauryl sulfate, starch, stearic acid, titanium dioxide, triacetin

Package Label


NDC 57896-455-10

GERICARE

Gentle Senna-Plus

Natural Vegetable Laxative

with Stool Softener

Standardized Senna Concentrate

COMPARE TO ACTIVE INGREDIENT

IN SENOKOT-S

1000 Tablets

Senna Plus

Senna Plus

Sennosides and Docusate Sodium TABLET

Product Information

Product Type Human otc drug label Item Code (Source) NDC:57896-455
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
SENNOSIDES SENNOSIDES 8.6 mg
DOCUSATE SODIUM DOCUSATE 50 mg

Inactive Ingredients

Ingredient Name Strength
cellulose, microcrystalline
CROSCARMELLOSE SODIUM
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
magnesium silicate
MAGNESIUM STEARATE
Mineral Oil
POLYETHYLENE GLYCOLS
HYPROMELLOSES
FD&C YELLOW NO. 5
FD&C YELLOW NO. 6
SODIUM BENZOATE
SODIUM LAURYL SULFATE
STARCH, CORN
STEARIC ACID
titanium dioxide
triacetin

Product Characteristics

Color Size Imprint Code Shape
yellow 10 mm CPC490 ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:57896-455-01 100 in 1 BOTTLE
2 NDC:57896-455-06 60 in 1 BOTTLE
3 NDC:57896-455-10 1000 in 1 BOTTLE

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part334 2000-01-01


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.